Home › Therapeutic areas › Oncology › Esophageal Cancer
Esophageal Cancer (3 companies)
Companies with an active program in Esophageal Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CHRS | Coherus Oncology | Oncology | 1 | Approved | $74.0M | 5 |
| KAPA | Kairos Pharma | Oncology | 1 | Phase 2 | $1.9M | 12 |
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | $3.12B | 17 |
No companies match.